发明名称 NOVEL COMPOSITION FOR EXTRACORPOREAL REDUCTION OF BETA AMYLOIDS AND PROCESS FOR PRODUCING THEREOF
摘要 <p>The present invention provides a safe reliable and economical process for preparing an improved dialysis fluid formulation effective for extracorporeal treatment through a blood filtration process of a Beta Amyloid associated pathological condition in a subject said process comprises preparing a composition comprising KLVFF peptide or a variant thereof as the capturing and binding agent and a carrier therefor and mixing said composition with a dialysate solution. The process utilizes a compact inexpensive and simple standard dialysis machine that extracorporeally removes Beta Amyloids without allowing escape of the Beta Amyloids back into a subject s body without having to intricately evaluate the performance and characteristics of a dialysis membrane and without putting the health condition of the subject at risk.</p>
申请公布号 IN2137MUN2014(A) 申请公布日期 2015.08.21
申请号 IN2014MU02137 申请日期 2014.10.27
申请人 AMYLEX PHARMACEUTICALS INC 发明人 SANTOS ROGELIO B. JR.;STEIN STANLEY;KASINATHAN CHINNASWAMY
分类号 C07K1/22;A61M1/14;A61M1/34 主分类号 C07K1/22
代理机构 代理人
主权项
地址